Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
オレキシン受容体アンタゴニスト
Document Type and Number:
Japanese Patent JP6424285
Kind Code:
B2
Abstract:
wherein W, X and Y1, Y2, Y3 and Y4 are defined herein, and their use in treating, preventing, ameliorating, controlling or reducing the risk of neurological or psychiatric disorders associated with orexin receptors.

Inventors:
Miles Stewart Congreave
John Andrew Christopher
Benjamin Gerald Taehan
Scvindel Sin Clair
Sarah Joan Abeth
Application Number:
JP2018072560A
Publication Date:
November 14, 2018
Filing Date:
April 04, 2018
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
Heptares Therapeutics Limited
International Classes:
C07D285/24; A61K31/5415; A61K31/542; A61P3/04; A61P3/10; A61P25/02; A61P25/04; A61P25/06; A61P25/20; A61P25/22; A61P25/28; A61P43/00; C07D417/04; C07D417/06; C07D513/04
Domestic Patent References:
JP2015521999A
JP56042897A
JP2004520387A
JP2009534304A
JP2008540574A
Foreign References:
WO2003053344A2
Other References:
DATABASE REGISTRY [ONLINE] Retrieved from STN,2007年10月26日,検索日:2017年2月22日,CAS Registry No. 951554-78-2, 951485-99-7, 951485-87-3, 951485-75-9
DATABASE REGISTRY [ONLINE] Retrieved from STN,2007年 7月10日,検索日:2017年2月22日,CAS Registry No. 941971-01-3, 941950-58-9, 941924-05-6, 941899-57-6, 941899-45-2
Rolfe, A. et al.,Microwave-assisted sequential one-pot protocol to benzothiadiazin-3-one-1,1-dioxides via a copper-catalyzed N-arylation strategy,Tetrahedron Letters,2009年,50(50),pp. 6935-6937
Attorney, Agent or Firm:
Norihito Yamao
Nagatoshi Shinagawa
Mizuhara Masahiro